A single-cell survey of cellular hierarchy in acute myeloid leukemia
Abstract Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput sin...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-020-00941-y |
id |
doaj-392d6af855674295ab08489b42a89bc6 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Junqing Wu Yanyu Xiao Jie Sun Huiyu Sun Haide Chen Yuanyuan Zhu Huarui Fu Chengxuan Yu Weigao E. Shujing Lai Lifeng Ma Jiaqi Li Lijiang Fei Mengmeng Jiang Jingjing Wang Fang Ye Renying Wang Ziming Zhou Guodong Zhang Tingyue Zhang Qiong Ding Zou Wang Sheng Hao Lizhen Liu Weiyan Zheng Jingsong He Weijia Huang Yungui Wang Jin Xie Tiefeng Li Tao Cheng Xiaoping Han He Huang Guoji Guo |
spellingShingle |
Junqing Wu Yanyu Xiao Jie Sun Huiyu Sun Haide Chen Yuanyuan Zhu Huarui Fu Chengxuan Yu Weigao E. Shujing Lai Lifeng Ma Jiaqi Li Lijiang Fei Mengmeng Jiang Jingjing Wang Fang Ye Renying Wang Ziming Zhou Guodong Zhang Tingyue Zhang Qiong Ding Zou Wang Sheng Hao Lizhen Liu Weiyan Zheng Jingsong He Weijia Huang Yungui Wang Jin Xie Tiefeng Li Tao Cheng Xiaoping Han He Huang Guoji Guo A single-cell survey of cellular hierarchy in acute myeloid leukemia Journal of Hematology & Oncology Acute myeloid leukemia Single-cell mRNA sequencing Microwell-seq Ribosomal protein Single-molecule real-time sequencing Cancer attractor |
author_facet |
Junqing Wu Yanyu Xiao Jie Sun Huiyu Sun Haide Chen Yuanyuan Zhu Huarui Fu Chengxuan Yu Weigao E. Shujing Lai Lifeng Ma Jiaqi Li Lijiang Fei Mengmeng Jiang Jingjing Wang Fang Ye Renying Wang Ziming Zhou Guodong Zhang Tingyue Zhang Qiong Ding Zou Wang Sheng Hao Lizhen Liu Weiyan Zheng Jingsong He Weijia Huang Yungui Wang Jin Xie Tiefeng Li Tao Cheng Xiaoping Han He Huang Guoji Guo |
author_sort |
Junqing Wu |
title |
A single-cell survey of cellular hierarchy in acute myeloid leukemia |
title_short |
A single-cell survey of cellular hierarchy in acute myeloid leukemia |
title_full |
A single-cell survey of cellular hierarchy in acute myeloid leukemia |
title_fullStr |
A single-cell survey of cellular hierarchy in acute myeloid leukemia |
title_full_unstemmed |
A single-cell survey of cellular hierarchy in acute myeloid leukemia |
title_sort |
single-cell survey of cellular hierarchy in acute myeloid leukemia |
publisher |
BMC |
series |
Journal of Hematology & Oncology |
issn |
1756-8722 |
publishDate |
2020-09-01 |
description |
Abstract Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput single-cell mRNA sequencing platform, we analyzed the cellular hierarchy of bone marrow samples from 40 patients and 3 healthy donors. We also used single-cell single-molecule real-time (SMRT) sequencing to investigate the clonal heterogeneity of AML cells. Results From the integrative analysis of 191727 AML cells, we established a single-cell AML landscape and identified an AML progenitor cell cluster with novel AML markers. Patients with ribosomal protein high progenitor cells had a low remission rate. We deduced two types of AML with diverse clinical outcomes. We traced mitochondrial mutations in the AML landscape by combining Microwell-seq with SMRT sequencing. We propose the existence of a phenotypic “cancer attractor” that might help to define a common phenotype for AML progenitor cells. Finally, we explored the potential drug targets by making comparisons between the AML landscape and the Human Cell Landscape. Conclusions We identified a key AML progenitor cell cluster. A high ribosomal protein gene level indicates the poor prognosis. We deduced two types of AML and explored the potential drug targets. Our results suggest the existence of a cancer attractor. |
topic |
Acute myeloid leukemia Single-cell mRNA sequencing Microwell-seq Ribosomal protein Single-molecule real-time sequencing Cancer attractor |
url |
http://link.springer.com/article/10.1186/s13045-020-00941-y |
work_keys_str_mv |
AT junqingwu asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT yanyuxiao asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jiesun asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT huiyusun asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT haidechen asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT yuanyuanzhu asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT huaruifu asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT chengxuanyu asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT weigaoe asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT shujinglai asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT lifengma asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jiaqili asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT lijiangfei asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT mengmengjiang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jingjingwang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT fangye asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT renyingwang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT zimingzhou asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT guodongzhang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT tingyuezhang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT qiongding asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT zouwang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT shenghao asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT lizhenliu asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT weiyanzheng asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jingsonghe asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT weijiahuang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT yunguiwang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jinxie asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT tiefengli asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT taocheng asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT xiaopinghan asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT hehuang asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT guojiguo asinglecellsurveyofcellularhierarchyinacutemyeloidleukemia AT junqingwu singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT yanyuxiao singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jiesun singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT huiyusun singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT haidechen singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT yuanyuanzhu singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT huaruifu singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT chengxuanyu singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT weigaoe singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT shujinglai singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT lifengma singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jiaqili singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT lijiangfei singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT mengmengjiang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jingjingwang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT fangye singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT renyingwang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT zimingzhou singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT guodongzhang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT tingyuezhang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT qiongding singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT zouwang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT shenghao singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT lizhenliu singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT weiyanzheng singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jingsonghe singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT weijiahuang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT yunguiwang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT jinxie singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT tiefengli singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT taocheng singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT xiaopinghan singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT hehuang singlecellsurveyofcellularhierarchyinacutemyeloidleukemia AT guojiguo singlecellsurveyofcellularhierarchyinacutemyeloidleukemia |
_version_ |
1724501245853433856 |
spelling |
doaj-392d6af855674295ab08489b42a89bc62020-11-25T03:47:56ZengBMCJournal of Hematology & Oncology1756-87222020-09-0113111910.1186/s13045-020-00941-yA single-cell survey of cellular hierarchy in acute myeloid leukemiaJunqing Wu0Yanyu Xiao1Jie Sun2Huiyu Sun3Haide Chen4Yuanyuan Zhu5Huarui Fu6Chengxuan Yu7Weigao E.8Shujing Lai9Lifeng Ma10Jiaqi Li11Lijiang Fei12Mengmeng Jiang13Jingjing Wang14Fang Ye15Renying Wang16Ziming Zhou17Guodong Zhang18Tingyue Zhang19Qiong Ding20Zou Wang21Sheng Hao22Lizhen Liu23Weiyan Zheng24Jingsong He25Weijia Huang26Yungui Wang27Jin Xie28Tiefeng Li29Tao Cheng30Xiaoping Han31He Huang32Guoji Guo33Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineWuhan Biobank Co., LTDWuhan Biobank Co., LTDWuhan Biobank Co., LTDBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of MedicineInstitute of Hematology, The First Affiliated Hospital, Zhejiang University School of MedicineState Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang UniversityInstitute of Applied Mechanics, Zhejiang UniversityInstitute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineInstitute of Hematology, The First Affiliated Hospital, Zhejiang University School of MedicineCenter for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineAbstract Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput single-cell mRNA sequencing platform, we analyzed the cellular hierarchy of bone marrow samples from 40 patients and 3 healthy donors. We also used single-cell single-molecule real-time (SMRT) sequencing to investigate the clonal heterogeneity of AML cells. Results From the integrative analysis of 191727 AML cells, we established a single-cell AML landscape and identified an AML progenitor cell cluster with novel AML markers. Patients with ribosomal protein high progenitor cells had a low remission rate. We deduced two types of AML with diverse clinical outcomes. We traced mitochondrial mutations in the AML landscape by combining Microwell-seq with SMRT sequencing. We propose the existence of a phenotypic “cancer attractor” that might help to define a common phenotype for AML progenitor cells. Finally, we explored the potential drug targets by making comparisons between the AML landscape and the Human Cell Landscape. Conclusions We identified a key AML progenitor cell cluster. A high ribosomal protein gene level indicates the poor prognosis. We deduced two types of AML and explored the potential drug targets. Our results suggest the existence of a cancer attractor.http://link.springer.com/article/10.1186/s13045-020-00941-yAcute myeloid leukemiaSingle-cell mRNA sequencingMicrowell-seqRibosomal proteinSingle-molecule real-time sequencingCancer attractor |